发明名称 |
CRYSTALLINE FORMS OF SODIUM 4-{[9-CHLORO-7-(2-FLUORO-6-METHOXYPHENYL)-5H -PYRIMIDO[5,4-D][2]BENZAZEPIN-2YL]AMINO}-2-METHOXYBENZOATE |
摘要 |
The present invention is directed to a compound of formula (I): or a crystalline form thereof, or a solvate thereof; to a solid pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula (I), or a crystalline form thereof, or a solvate thereof, and at least one pharmaceutically acceptable carrier or diluent, and to the use of a compound of formula (I), or a crystalline form thereof, or a solvate thereof, for treating a patient suffering from, or subject to, a disease, disorder, or condition mediated by Aurora kinase, and methods related thereto. |
申请公布号 |
EP2536279(A1) |
申请公布日期 |
2012.12.26 |
申请号 |
EP20110745114 |
申请日期 |
2011.02.15 |
申请人 |
MILLENNIUM PHARMACEUTICALS, INC. |
发明人 |
ARMITAGE, IAN;COOPER, MARTIN, I.;EDDLESTON, MARK, D.;FAIBER, NEIL, C.;MCCUBBIN, QUENTIN, J.;WATT, STEPHEN, W. |
分类号 |
A01N43/00;A61K31/55;A61P35/00;C07D487/04;C07D498/00 |
主分类号 |
A01N43/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|